Transform drug discovery with us
Our vision
Join us
Senior or Principal Scientist
- Ph.D. in biomedical engineering or related field with 4+ years of post-Ph.D. experience (M.S. with equivalent experience will be considered)
- Minimum of 5 years of hands-on experience with molecular biology and cell-based assays
- Minimum of 2 years of experience supervising and managing a small team; industry experience is a plus
- Solid background in oncology; experience with ADC is a plus
- Track record of successfully designing and conducting experiments
- Excellent communication and interpersonal skills, time/resource management, attention to detail, and proven success working in matrix environments
SUMMARY:
The successful candidate will conduct experiments and lead a small team in planning and executing experiments. This position will be on-site in our R&D laboratory in Charlottesville, VA.
RESPONSIBILITIES:
- Work with scientific leads to develop strategies for R&D programs
- Plan and design experiments in support of R&D program strategies
- Conduct experiments and manage a subteam of 1-2 laboratory personnel
- Managing and balancing workload, prioritizing team members’ time, training and onboarding
- Overseeing work quality and pace of team members, providing feedback and coaching as needed
- Analysis, interpretation, and recording of experimental data
- Interfacing with CROs as needed to provide input on study design
- Present study design and results at project team and other ZielBio-internal meetings. Present key findings at external conferences
- Participate in preparing relevant scientific documents such as regulatory applications or manuscripts
ABOUT ZIELBIO:
ZielBio, Inc. is a clinical-stage biotechnology company that identifies novel high value disease targets and develops therapeutic interventions to improve patient outcomes. ZielBio has a rich pipeline with lead candidate ZB131 currently in the clinic. ZB131 is a proprietary humanized monoclonal antibody against cell surface plectin (CSP), a target that is highly expressed on the plasma membrane of multiple types of cancer cells, including ovarian, pancreatic, cholangiocarcinoma, lung, and colorectal.
HOW TO APPLY:
Interested applicants should send their CV, bibliography, and a brief statement of research interests to Dr. Lindsey Brinton (lbrinton@zielbio.com). Letters of recommendation may be required later in the process.
Associate Director, Project Management
- M.S./Ph.D. in a scientific-related field
- At least five years in the pharmaceutical/biotechnology industry
- At least 3 years’ experience in project management
- Solid understanding of drug discovery and early development
- Experience in using project management tools
- Excellent communication and interpersonal skills, time/resource management, attention to detail, and proven success working in matrix environments
SUMMARY:
The Project Manager is responsible for managing the resources, timelines and budgets for discovery and early translational programs at ZielBio.
RESPONSIBILITIES:
- Work with scientific leads and head of program management to identify critical path activities, milestones, gaps and challenges and develop plans accordingly to meet program goals.
- Clearly and timely communicate timeline expectations, changes, issues or relevant information to managers and colleagues as appropriate.
- Implement strategies for keeping track of internal and external scientific activities and timelines; track those activities.
- Manage contractual aspects of nonclinical external collaborations.
- Establish collaborative relationships with external vendors and communicate proactively when potential issues/challenges arise on studies and/or timelines are not being met.
ABOUT ZIELBIO:
ZielBio is an early-stage biotechnology company that identifies novel high value disease targets and develops therapeutic interventions to improve patient outcomes. ZielBio has a rich pipeline. Its lead candidate ZB131 is currently in the clinic and is a proprietary humanized monoclonal antibody against cell surface plectin (CSP), a target that is highly expressed on the plasma membrane of multiple types of cancer cells, including ovarian, pancreatic, lung, and colorectal.
